Prostate Cancer :: Obese Men Face Risks From Prostate Cancer
Obese men face an increased risk of dying from prostate cancer and doctors should be especially thorough when checking these patients for the disease, a new study suggests.
Obese men face an increased risk of dying from prostate cancer and doctors should be especially thorough when checking these patients for the disease, a new study suggests.
After surgery to remove a cancerous prostate, the malignancy is more likely to recur among obese men than in those of normal weight, a new study shows.
Hasan Mukhtar of the University of Wisconsin, and team, gave high doses of pomegranate extract to mice that had been bred to have weak immune systems.
A new study, using a unique detection method, has led scientists to identify several genes whose rearrangements in prostate cancer cells may play a role in the development and progression of the disease. Researchers at the University of Michigan, Ann Arbor, report that two genes, ETV1 and ERG, which previously were implicated as cancer-causing gene rearrangements in Ewing’s sarcoma (a relatively rare bone cancer), are now seen as important cancer-causing genes in prostate cancer. Closer analysis showed how rearrangement of these genes was responsible for their cancer-causing potential. The research appears in the October 28, 2005, issue of Science and was supported by the National Cancer Institute (NCI), part of the National Institutes of Health.
A new study shows that testing blood samples for antibodies that target prostate cancer cells may help identify patients with early stages of the disease.
Diets high in refined grain products and processed meats could raise the risk of prostate cancer risk, say Canadian researchers.
Dr. Dean Ornish and associates at the University of California, San Francisco, recruited 93 men who had chosen the option of ‘watchful waiting’ for their early-stage, non-aggressive prostate cancer.
Scientists from Britain’s Institute of Cancer Research say they’ve developed a technique to markedly help in predicting the behavior of prostate cancer.
A new study indicates there is no specific PSA value that has both high sensitivity and high specificity for monitoring healthy men for prostate cancer, but rather there is a continuum of prostate cancer risk at all values of PSA, according to a study in the July 6 issue of JAMA.
In patients with locally advanced prostate cancer, a three-pronged approach to therapy can achieve a high level of tumor control, researchers at the University of Virginia in Charlottesville report.